A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda

Abstract Background Until recently, due to widespread prevalence of molecular markers associated with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) resistance in east and southern Africa, seasonal malaria chemoprevention (SMC) has not been used at scale in this region. This study assessed the...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Anthony Nuwa, Kevin Baker, Craig Bonnington, Musa Odongo, Tonny Kyagulanyi, John Baptist Bwanika, Sol Richardson, Jane Nabakooza, Jane Achan, Richard Kajubi, David Salandini Odong, Maureen Nakirunda, Godfrey Magumba, Geofrey Beinomugisha, Madeleine Marasciulo-Rice, Hilda Abio, Christian Rassi, Damian Rutazaana, Denis Rubahika, James Tibenderana, Jimmy Opigo
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2023
Subjects:
Season malaria chemoprevention
Protective efficacy
Malaria case
Malaria episode
Resistance markers
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Arctic
Meier
Online Access:https://doi.org/10.1186/s12936-023-04488-4
https://doaj.org/article/ed1aa68f39cc48dda7a88164e2a5f605

Similar Items